The Heart Rhythm Institute pursues a broad-based research program in cardiac arrhythmias that includes basic and clinical investigation. This comprehensive program has produced important discoveries and advances by including scientists and clinicians from many fields, including cardiology, electrophysiology, immunology, cell biology and pharmacology. The synergism produced by discussion, accessibility, and cross-pollination of many disciplines has resulted in significant contributions to the field.

Some of HRI's  research includes:

  • Prevention of post-infarction sudden cardiac death ischemia-American Heart Association
  • Studying the role of surviving myocardial bundles within the infarct scar in ischemia induced ventricular tachycardia/fibrillation-Presbyterian Health Foundation
  • Investigating magnetic navigation system for electrophysiological mapping-Stereotaxis Corporation
  • Non-Invasive Therapy for Atrial Fibrillation-National Institute of Health
  • Clinical study for the endoscopic ablation system-Cardiofocus
  • Study of light ring balloon catheter atrial fibrillation-Cardiofocus Corporation
  • Thoracoscopically assisted epicardial bilateral pulmonary vein isolation for atrial fibrillation-Atricure Corporation
  • Endocardial ablation of typical atrial flutter and a clinical study for ablation in patients with ventricular tachycardia-Biosense Webster
  • Pharmacological approach to atrial fibrillation-CV Therapeutics
  • Evaluate a contact sensor catheter for ablation-Endosense
  • Pharmacological study for subjects with non-valvular atrial fibrillation-Johnson & Johnson
  • Pharmacological study for the prevention of recurrent, symptomatic atrial fibrillation-Reliant
  • Focused ultrasound for the treatment of atrial fibrillation-ProRhythm Corporation